Technology News and Research

RSS

Cepheid announces international availability of updated Xpert Carba-R test to identify Superbugs

Cepheid today announced the international availability of an update to Xpert Carba-R, with the addition of two newly emerging carbapenemase genes, OXA-181 and OXA-232. The on-demand, molecular test also detects and differentiates among the five most prevalent mechanisms of carbapenem resistance, namely KPC, NDM, VIM, IMP-1 and OXA-48.

29 Jul 2015

GE Healthcare to invest more than $1 billion over five years in enhanced training for healthcare professionals

In developed countries like the U.S., Europe and parts of Asia, healthcare leaders are trying to optimize efficiency, systems integration, data analytics and achieve greater productivity. In emerging economies, enabling access to affordable, basic primary care is often the most pressing concern. Healthcare systems around the world face a wide range of difficult challenges. All could benefit from training and education solutions focused specifically on their particular needs.

29 Jul 2015

Henry Schein reports net sales of $2.6 billion for second quarter 2015

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record second quarter financial results.

29 Jul 2015

$UO-led effort on fractal-based nerve connections granted U.S. patent$

UO-led effort on fractal-based nerve connections granted U.S. patent

Richard Taylor's vision of using artificial fractal-based implants to restore sight to the blind -- part of a far-reaching concept that won an innovation award this year from the White House -- is now covered under a broad U.S. patent.

29 Jul 2015

Lark Technologies' interactive, health-coaching app now available for Android and Apple users

Lark Technologies, Inc. today announced expanded availability for Lark Chat, the company's interactive, health-coaching app designed to help people eat healthier and get more active in order to achieve their personal heath and weight-loss goals. Lark Chat is now available for free to download on all Android devices as well as iPhone 4 and 5, and pre-installed on all new Samsung phones.

29 Jul 2015

Researchers explore impact of nutrients, probiotics before and during pregnancy on mothers and babies

Researchers in the United Kingdom (Southampton), Singapore and New Zealand (Auckland) from the EpiGen Global Research Consortium are to trial the use of a combination of nutrients and probiotics before and during pregnancy in a bid to improve the health of mothers and their babies.

29 Jul 2015

Codman Neuro introduces new platform of embolic coils for treatment of brain aneurysms

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has introduced a new platform of embolic coils for the treatment of brain aneurysms, supported by an enhanced detachment system designed to improve microcatheter stability and provide an optimized detachment zone for coils.

29 Jul 2015

BioCision signs deal to develop CoolCell freezing systems for Cook Regentec’s CellSeal vials

BioCision, LLC today announced that they have entered into an exclusive partnership with Cook Regentec to develop two custom CoolCell controlled-rate cell freezing systems for Cook’s closed-system cell therapy CellSeal vials.

29 Jul 2015

‘Digital Doctor’ study examines attitudes of primary care physicians to new healthcare technologies

Healthcare apps and wearable tech have a long future in the treatment of patients, according to a panel of Primary Care Physicians (PCPs) interviewed as part of a newly launched Ipsos Healthcare study.

29 Jul 2015

New consortium aims to develop precision medicines for globally devastating diseases

An innovative new Consortium will act as a ‘match-making’ service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases.

29 Jul 2015

inSleep Health receives FDA clearance for Cloud9 Anti-Snoring System

inSleep Health announced today that it has received 510(K) clearance for the company's Cloud9 Anti-Snoring System. The indication for use is to reduce or eliminate simple snoring in adults. Cloud9 is a prescription device for home use. This is the first clinically proven device, using continuous low positive airway pressure, specifically labeled to treat simple snoring.

29 Jul 2015

Facial motion capture technology can help identify different speech disorders in children

Facial motion capture - the same technology used to develop realistic computer graphics in video games and movies - has been used to identify differences between children with childhood apraxia of speech and those with other types of speech disorders, finds a new study by NYU's Steinhardt School of Culture, Education, and Human Development.

29 Jul 2015

New polymer gel could help create swallowable devices for ultra-long drug delivery

Medical devices designed to reside in the stomach have a variety of applications, including prolonged drug delivery, electronic monitoring, and weight-loss intervention. However, these devices, often created with nondegradable elastic polymers, bear an inherent risk of intestinal obstruction as a result of accidental fracture or migration. As such, they are usually designed to remain in the stomach for a limited time.

29 Jul 2015

Yale researchers find improvements in mortality, hospitalizations and outcomes among Medicare patients

In a 15-year study of older Medicare patients, Yale School of Medicine researchers saw an estimated 20% drop in mortality, about 30% fewer hospitalizations, and 40% reduction in deaths after hospitalization.

29 Jul 2015

Point-of-care diagnostics for Ebola

In a recent DECODED research profile, Integrated DNA Technologies (IDT), details how IDT scientists Kristin Beltz and Dr Scott Rose are collaborating with Dr Brian Taylor’s research team at Battelle (Aberdeen, MD, USA) to design and validate a RT-qPCR assay that can detect the Ebola virus in the field.

From Integrated DNA Technologies 28 Jul 2015

Oxford Gene Technology expands portfolio of fluorescence in situ hybridisation probes

Oxford Gene Technology (OGT), The Molecular Genetics Company, is extending its portfolio of Cytocell® Pathology FISH probes with the addition of eight new probes. OGT offers the widest range of fluorescence in situ hybridisation (FISH) probes on the market, delivering a cost-effective and reliable solution for anyone engaged in FISH.

From Oxford Gene Technology 28 Jul 2015

German life sciences entrepreneurs granted option to develop Aeterna Zentaris’ oral allogenic tumor vaccine technology

Aeterna Zentaris Inc. today announced that it has granted to German life sciences entrepreneurs with a proven track-record of funding the development and commercialization of biotechnology, an option to license the Company's live recombinant oral allogenic tumor vaccine technology, including AEZS-120, the most advanced product candidate for prostate cancer which is ready to enter a Phase 1 clinical trial.

28 Jul 2015

VolitionRx selects Global Specimen Solutions to support U.S. market entry of NuQ colorectal cancer tests

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has engaged the services of a specialty specimen management clinical research organization, Global Specimen Solutions, Inc., to support initial U.S. market entry of its NuQ colorectal cancer tests.

28 Jul 2015

Champions Oncology's revenue increases 32% to $3.2 million in fourth quarter 2015

Champions Oncology, Inc., engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced its financial results for the year ended April 30, 2015.

28 Jul 2015

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Cepheid and FIND today unveiled the GeneXpert Omni, the world's most portable molecular diagnostics system enabling unprecedented access to accurate, fast and potentially life-saving diagnosis for patients suspected of TB, HIV and Ebola in even the most remote areas of the world.

28 Jul 2015

Technology News and Research

Cepheid announces international availability of updated Xpert Carba-R test to identify Superbugs

GE Healthcare to invest more than $1 billion over five years in enhanced training for healthcare professionals

Henry Schein reports net sales of $2.6 billion for second quarter 2015

UO-led effort on fractal-based nerve connections granted U.S. patent

Lark Technologies' interactive, health-coaching app now available for Android and Apple users

Researchers explore impact of nutrients, probiotics before and during pregnancy on mothers and babies

Codman Neuro introduces new platform of embolic coils for treatment of brain aneurysms

BioCision signs deal to develop CoolCell freezing systems for Cook Regentec’s CellSeal vials

‘Digital Doctor’ study examines attitudes of primary care physicians to new healthcare technologies

New consortium aims to develop precision medicines for globally devastating diseases

inSleep Health receives FDA clearance for Cloud9 Anti-Snoring System

Facial motion capture technology can help identify different speech disorders in children

New polymer gel could help create swallowable devices for ultra-long drug delivery

Yale researchers find improvements in mortality, hospitalizations and outcomes among Medicare patients

Point-of-care diagnostics for Ebola

Oxford Gene Technology expands portfolio of fluorescence in situ hybridisation probes

German life sciences entrepreneurs granted option to develop Aeterna Zentaris’ oral allogenic tumor vaccine technology

VolitionRx selects Global Specimen Solutions to support U.S. market entry of NuQ colorectal cancer tests

Champions Oncology's revenue increases 32% to $3.2 million in fourth quarter 2015

Cepheid, FIND unveil new portable molecular diagnostics system for patients suspected of TB, HIV and Ebola

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News